NERV
Minerva Neurosciences Inc
3.20$
-3.6%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | – | |
| – | – | – | – | – | -4.3% | -32.9% | +57.4% | +824.6% | +9.1% | -42.2% | -91.6% | +263.9% | -27.5% | -75.8% | |
| – | – | – | – | – | – | – | – | – | – | -100.2% | – | – | – | – | |
| – | -7.2% | +28.7% | +5,956.4% | -56.8% | +10.3% | +48.0% | +15.3% | +66.6% | -62.1% | +45.4% | -54.3% | -13.3% | -6.3% | -51.6% | |
| – | – | +139.2% | +385.1% | -36.7% | +28.7% | +11.9% | +54.3% | +5.3% | -2.5% | -22.9% | -20.6% | -1.6% | -4.5% | -6.1% | |
| – | +40.2% | +100.8% | +1,628.2% | -52.4% | +15.6% | +36.4% | +25.6% | +46.7% | -48.2% | +15.3% | -44.4% | -8.4% | -5.5% | -30.9% | |
| – | – | – | – | – | – | – | – | – | – | -2,556.2% | – | – | – | – | |
| – | – | – | +3,339.1% | -48.6% | -2.2% | -40.4% | -82.0% | +1,338.2% | -100.0% | – | +17.1% | +11.8% | -44.9% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | -2,764.1% | – | – | – | -20,492.7% | |
| – | – | – | +3,431.5% | -48.6% | -2.2% | -1,010.3% | – | -235.1% | – | – | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -2,671.1% | – | – | – | -20,492.7% | |
| – | – | – | – | – | – | – | – | – | – | -2,238.9% | – | – | – | -4,971.2% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.